BACKGROUND: Little is known about the long-term outcomes of obese living kidney donors (OLKDs). We undertook this study to describe renal outcomes of OLKDs several years after donation. METHODS: We invited 101 OLKDs for follow-up health evaluation. RESULTS: Thirty-six subjects (35.6%) completed evaluation at 6.8±1.5 years postdonation. The mean estimated glomerular filtration rate (eGFR) using the abbreviated modification of diet in renal disease (MDRD) equation (MDRD-eGFR) at follow-up was 72.1±16.3 (range: 42-106) mL/min per 1.73 m, and 47.2% of subjects had an MDRD-eGFR of 30 to 59. The absolute decrease in MDRD-eGFR from the time of donation to follow-up was 27.2 ± 13.1 mL/min per 1.73 m (P<0.001 on paired t test), which represents a 29.2% drop in the serial MDRD-eGFRs. Seven subjects (19.4%) had microalbuminuria (30-300 μg/mg creatinine). Subjects with microabuminuria were more likely to have MDRD-eGFR of less than 60 mL/min per 1.73 m (P=0.021). Subjects whose body mass index was greater than or equal to 35 kg/m (n=14) were found to have an absolute decrement in MDRD-eGFR similar to those with body mass index less than 35 kg/m (31.5 ± 15.6 and 24.7 ± 11.0 mL/min/1.73 m, respectively; P=not significant). Fifteen (41.6%) were hypertensive at follow-up. CONCLUSIONS: On medium-term follow-up, a large proportion of OLKDs will have a MDRD-eGFR of less than 60 mL/min per 1.73 m, and the likelihood increases markedly among those who develop microalbuninuria. This raises concern for hyperfiltration injury. Furthermore, OLKDs experience a substantial incidence of hypertension. Caution is advised in selecting OLKDs pending further data on long-term outcomes.
BACKGROUND: Little is known about the long-term outcomes of obese living kidney donors (OLKDs). We undertook this study to describe renal outcomes of OLKDs several years after donation. METHODS: We invited 101 OLKDs for follow-up health evaluation. RESULTS: Thirty-six subjects (35.6%) completed evaluation at 6.8±1.5 years postdonation. The mean estimated glomerular filtration rate (eGFR) using the abbreviated modification of diet in renal disease (MDRD) equation (MDRD-eGFR) at follow-up was 72.1±16.3 (range: 42-106) mL/min per 1.73 m, and 47.2% of subjects had an MDRD-eGFR of 30 to 59. The absolute decrease in MDRD-eGFR from the time of donation to follow-up was 27.2 ± 13.1 mL/min per 1.73 m (P<0.001 on paired t test), which represents a 29.2% drop in the serial MDRD-eGFRs. Seven subjects (19.4%) had microalbuminuria (30-300 μg/mg creatinine). Subjects with microabuminuria were more likely to have MDRD-eGFR of less than 60 mL/min per 1.73 m (P=0.021). Subjects whose body mass index was greater than or equal to 35 kg/m (n=14) were found to have an absolute decrement in MDRD-eGFR similar to those with body mass index less than 35 kg/m (31.5 ± 15.6 and 24.7 ± 11.0 mL/min/1.73 m, respectively; P=not significant). Fifteen (41.6%) were hypertensive at follow-up. CONCLUSIONS: On medium-term follow-up, a large proportion of OLKDs will have a MDRD-eGFR of less than 60 mL/min per 1.73 m, and the likelihood increases markedly among those who develop microalbuninuria. This raises concern for hyperfiltration injury. Furthermore, OLKDs experience a substantial incidence of hypertension. Caution is advised in selecting OLKDs pending further data on long-term outcomes.
Authors: C R Gross; E E Messersmith; B A Hong; S G Jowsey; C Jacobs; B W Gillespie; S J Taler; A J Matas; A Leichtman; R M Merion; H N Ibrahim Journal: Am J Transplant Date: 2013-09-06 Impact factor: 8.086
Authors: Harini A Chakkera; Yu-Hui H Chang; Leslie F Thomas; Ramesh T Avula; Hatem Amer; Lilach O Lerman; Aleksandar Denic; Andrew D Rule Journal: Transplant Direct Date: 2015-02-01
Authors: Krista L Lentine; Mark A Schnitzler; Huiling Xiao; David Axelrod; Amit X Garg; Janet E Tuttle-Newhall; Daniel C Brennan; Dorry L Segev Journal: Transplantation Date: 2014-02-15 Impact factor: 4.939
Authors: Courtenay M Holscher; Tanveen Ishaque; Jacqueline M Garonzik Wang; Christine E Haugen; Sandra R DiBrito; Kyle R Jackson; Abimereki D Muzaale; Allan B Massie; Fawaz Al Ammary; Shane E Ottman; Macey L Henderson; Dorry L Segev Journal: Am J Transplant Date: 2018-08-31 Impact factor: 8.086
Authors: Courtenay M Holscher; Sunjae Bae; Alvin G Thomas; Macey L Henderson; Christine E Haugen; Sandra R DiBrito; Abimereki D Muzaale; Jacqueline M Garonzik Wang; Allan B Massie; Krista L Lentine; Dorry L Segev Journal: Transplantation Date: 2019-06 Impact factor: 4.939
Authors: Marica Cutajar; Rachel Hilton; Jonathon Olsburgh; Stephen D Marks; David L Thomas; Tina Banks; Christopher A Clark; Isky Gordon Journal: Eur Radiol Date: 2015-02-11 Impact factor: 5.315
Authors: Tanja Herrler; Hao Wang; Anne Tischer; Peter Bartenstein; Karl-Walter Jauch; Markus Guba; Markus Diemling; Cyril Nimmon; Marcus Hacker Journal: EJNMMI Res Date: 2012-01-20 Impact factor: 3.138